Briefing
|
- Blockchain-Based Genome Trading – Harvard professor George Church launched Nebula Genomics, startup developing genome trading platform on blockchain, where individuals can sell genome data to buyers, such as biotech and pharmaceutical companies
- Exchange Currency – Will use Nebula tokens for trading, which data buyers and individuals can acquire using fiat money
- Platform Structure – Individuals can have genome sequenced at Nebula’s facilities for under $1,000, or through other sources, and join network, connecting them directly to prospective buyers, without need for middlemen
- Protecting Information – Data owners’ identity will remain anonymous, while buyers will be required to disclose full identity
- Encouraging Genome Sequencing – Aims to encourage more people to have genome sequenced, by giving opportunity to profit from their data, as opposed to sequencing company owning and selling genome data
- Availability – No specific date given, but company expects platform to launch before end-2018
|